Latest News

Veryan Premarket Approval

Veryan Receives PreMarket Approval

5th October 2018

Horsham, UK. 05 October 2018: Seroba Investee, Veryan Medical Ltd, today announced that the Company has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System from the U.S. Food & Drug Administration (FDA).  The device is approved for […]

Read More
Quanta News

Quanta Wins Industrial Product Design 2018

1st October 2018

Alcester, UK, 1 October 2018: Quanta Dialysis Technologies Ltd (“Quanta”), a medical device company pioneering innovative haemodialysis products for dialysis patients, is pleased to announce that it has won the “Industrial Product Design of the Year” award at the Plastics […]

Read More
Endotronix News

Endotronix Raises $45M Series D Financing

14th September 2018

Ireland and USA, 14 Sept 2018. Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million. The round was led by LSP, investing […]

Read More
Novate News

Novate Acquired By BTG for Up To $150m

7th September 2018

Dublin, Ireland 7 Sept 2018 – BTG plc (LSE:BTG) (BTG) and Seroba’s portfolio company, Novate , today announced the signing of a definitive agreement in which BTG has acquired Novate for a $20m upfront payment with additional potential milestones of […]

Read More
Labcyte News Logo

Labcyte Partners with GP-write in Large-Scale Genomic Testing

17th July 2018

17 July, 2018, California, USA.   Labcyte Inc., today announced an agreement with the Center for Excellence in Engineering Biology (CEEB), an independent nonprofit that is managing initial planning and coordination of efforts for the Genome Project-write (GP-write). As part of […]

Read More
Pq Bypass

PQ Bypass Reports Positive 12-Month Results

28th June 2018

28 June 2018.  Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long blockages in the superficial femoral artery (SFA).  The data were presented as a […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top